Chiara Dalle Fratte

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Chronic Myeloid Leukemia

Peritoneal Dialysis

Systematic Review

Patient Reported

Top Venues

International journal of molecular sciences

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

British journal of clinical pharmacology

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Chiara Dalle Fratte, Jerry Polesel, Sara Gagno, Bianca Posocco, Elena De Mattia, Rossana Roncato, Marco Orleni, Fabio Puglisi, Michela Guardascione, Angela Buonadonna, Giuseppe Toffoli, Erika Cecchin
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis. International journal of molecular sciences 24 (4) (2023)
Chiara Dalle Fratte, Jerry Polesel, Sara Gagno, Bianca Posocco, Elena De Mattia, Rossana Roncato, Marco Orleni, Fabio Puglisi, Michela Guardascione, Angela Buonadonna, Giuseppe Toffoli, Erika Cecchin
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis. International journal of molecular sciences 24 (4) (2023)
Chiara Dalle Fratte, Jerry Polesel, Sara Gagno, Bianca Posocco, Elena De Mattia, Rossana Roncato, Marco Orleni, Fabio Puglisi, Michela Guardascione, Angela Buonadonna, Giuseppe Toffoli, Erika Cecchin
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis. International journal of molecular sciences 24 (4) (2023)
Chiara Dalle Fratte, Jerry Polesel, Sara Gagno, Bianca Posocco, Elena De Mattia, Rossana Roncato, Marco Orleni, Fabio Puglisi, Michela Guardascione, Angela Buonadonna, Giuseppe Toffoli, Erika Cecchin
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis. International journal of molecular sciences 24 (4) (2023)
Sara Gagno, Chiara Dalle Fratte, Bianca Posocco, Angela Buonadonna, Arianna Fumagalli, Michela Guardascione, Giuseppe Toffoli, Erika Cecchin
Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation. Pharmacogenomics (2023)
Sara Gagno, Angela Buonadonna, Chiara Dalle Fratte, Michela Guardascione, Martina Zanchetta, Bianca Posocco, Marco Orleni, Giovanni Canil, Rossana Roncato, Erika Cecchin, Giuseppe Toffoli
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2023)
Chiara Dalle Fratte, Jerry Polesel, Sara Gagno, Bianca Posocco, Elena De Mattia, Rossana Roncato, Marco Orleni, Fabio Puglisi, Michela Guardascione, Angela Buonadonna, Giuseppe Toffoli, Erika Cecchin
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis. International journal of molecular sciences 24 (4) (2023)
Chiara Dalle Fratte, Sara Gagno, Rossana Roncato, Jerry Polesel, Martina Zanchetta, Mauro Buzzo, Bianca Posocco, Elena De Mattia, Rachele Borsatti, Fabio Puglisi, Luisa Foltran, Michela Guardascione, Angela Buonadonna, Erika Cecchin, Giuseppe Toffoli
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients. British journal of clinical pharmacology (2022)
Silvia Mezzalira, Elena De Mattia, Michela Guardascione, Chiara Dalle Fratte, Erika Cecchin, Giuseppe Toffoli
Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy Outcomes. International journal of molecular sciences 20 (21) (2019)